Literature DB >> 23363560

Adult-onset immunodeficiency--why is it important in rheumatology?

Hans-Hartmut Peter.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23363560      PMCID： PMC3745649          DOI： 10.1186/ar4121

Source DB:  PubMed          Journal:  Arthritis Res Ther        ISSN： 1478-6354            Impact factor:   5.156


× No keyword cloud information.
  9 in total

1.  X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options.

Authors:  Michael H Albert; Tanja C Bittner; Shigeaki Nonoyama; Lucia Dora Notarangelo; Siobhan Burns; Kohsuke Imai; Teresa Espanol; Anders Fasth; Isabelle Pellier; Gabriele Strauss; Tomohiro Morio; Benjamin Gathmann; Jeroen G Noordzij; Cristina Fillat; Manfred Hoenig; Michaela Nathrath; Alfons Meindl; Philipp Pagel; Uwe Wintergerst; Alain Fischer; Adrian J Thrasher; Bernd H Belohradsky; Hans D Ochs
Journal:  Blood       Date:  2010-02-19       Impact factor: 22.113

2.  Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency.

Authors:  Bodo Grimbacher; Andreas Hutloff; Michael Schlesier; Erik Glocker; Klaus Warnatz; Ruth Dräger; Hermann Eibel; Beate Fischer; Alejandro A Schäffer; Hans W Mages; Richard A Kroczek; Hans H Peter
Journal:  Nat Immunol       Date:  2003-02-10       Impact factor: 25.606

3.  Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.

Authors:  Naomi Takahashi; Kenji Matsumoto; Hirohisa Saito; Toshihiro Nanki; Nobuyuki Miyasaka; Tetsuji Kobata; Miyuki Azuma; Sang-Kyou Lee; Shuki Mizutani; Tomohiro Morio
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

Review 4.  Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis.

Authors:  Sebastian Fn Bode; Kai Lehmberg; Andrea Maul-Pavicic; Thomas Vraetz; Gritta Janka; Udo Zur Stadt; Stephan Ehl
Journal:  Arthritis Res Ther       Date:  2012-06-08       Impact factor: 5.156

Review 5.  Immunoglobulin class-switch recombination deficiencies.

Authors:  Anne Durandy; Sven Kracker
Journal:  Arthritis Res Ther       Date:  2012-07-30       Impact factor: 5.156

Review 6.  Idiopathic CD4 lymphocytopenia: a case of missing, wandering or ineffective T cells.

Authors:  Dimitrios Zonios; Virginia Sheikh; Irini Sereti
Journal:  Arthritis Res Ther       Date:  2012-08-31       Impact factor: 5.156

Review 7.  An update on the hyper-IgE syndromes.

Authors:  Patrick F K Yong; Alexandra F Freeman; Karin R Engelhardt; Steven Holland; Jennifer M Puck; Bodo Grimbacher
Journal:  Arthritis Res Ther       Date:  2012-11-30       Impact factor: 5.156

Review 8.  Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy.

Authors:  Anna R Huppler; Shrinivas Bishu; Sarah L Gaffen
Journal:  Arthritis Res Ther       Date:  2012-07-23       Impact factor: 5.156

Review 9.  Common variable immunodeficiency: an update.

Authors:  Ulrich Salzer; Klaus Warnatz; Hans Hartmut Peter
Journal:  Arthritis Res Ther       Date:  2012-09-24       Impact factor: 5.156
  9 in total
  1 in total

1.  Expanding TREC and KREC Utility in Primary Immunodeficiency Diseases Diagnosis.

Authors:  Ilya Korsunskiy; Oleg Blyuss; Maria Gordukova; Natalia Davydova; Alexey Zaikin; Natalia Zinovieva; Sergey Zimin; Robert Molchanov; Aminat Salpagarova; Alina Eremeeva; Maxim Filipenko; Andrey Prodeus; Anatoliy Korsunskiy; Peter Hsu; Daniel Munblit
Journal:  Front Immunol       Date:  2020-03-03       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.